| Feng Xiaoying | 01-Feb-23 | | FD | | |
| Zeng Ming | 25-Jun-21 | | Non-Executive Director | | |
| Ma Wei Ying | 15-Jan-21 | | INED | | |
| Pan Rongrong | 15-Jan-21 | | INED | | |
| Li Ching Yi | 16-Oct-20 | | CoSec | | |
| Xie Li | 27-Jan-25 | 13-Feb-26 | ED | | She plans to devote more time to her personal matters. |
| Yan Jun | 16-Aug-20 | 27-Jan-25 | ED | | Resigned to focus on the Company's technology research and development work. Dr. Yan has confirmed that he has no disagreement with the Board and there are no other matters relating to his resignation that need to be brought to the attention of the shareholders of the Company. |
| Bai Rui | 16-Aug-20 | 01-Feb-23 | CoSec | | Other professional commitments in legal affairs of the Company |
| Gong Yingying | 09-Dec-14 | 01-Feb-23 | Ch, CEO, Co-Fdr | | In order for the Company to better comply with code provision C.2.1 of the Corporate Governance Code set out in Appendix 14 to the Listing Rules |
| Yang Jing | 14-Aug-18 | 01-Feb-23 | FD, Pres | | Personal commitments in building a medical ecosystem by innovative therapeutics and technologies |
| Zhang Shi | 03-Jul-20 | 01-Feb-23 | ED, SVP | | Professional commitments in government affairs |
| Yang Jing | | 01-Feb-23 | ED | | Personal commitments in building a medical ecosystem by innovative therapeutics and technologies |
| Bai Rui | | 01-Feb-23 | J-CoSec | | Other professional commitments in legal affairs of the Company |
| Xu Jiming | 01-Feb-23 | 07-Sep-22 | CEO | | |
| Gao Yongmei | 16-Aug-20 | 26-Sep-21 | Non-Executive Director | | |
| Xu Jiming | 31-Mar-16 | 30-Dec-20 | Co-Fdr, Dir | | |
| He Zhi | 31-Mar-16 | 16-Aug-20 | Co-Fdr, Dir | | |
| Sun Zhe | 16-Mar-15 | 03-Jul-20 | Co-Fdr, Dir | | |
| Zhang Linqi | 15-Jan-21 | 08-Sep-15 | INED | | |
| Feng Xiaoying | 01-Feb-23 | 16-Jan-03 | CoSec | | |
